101 related articles for article (PubMed ID: 2527430)
1. Coagulation and fibrinolysis during the normal menstrual cycle.
Siegbahn A; Odlind V; Hedner U; Venge P
Ups J Med Sci; 1989; 94(2):137-52. PubMed ID: 2527430
[TBL] [Abstract][Full Text] [Related]
2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic status and fibrinolytic response potential at different phases of the menstrual cycle.
Koh SC; Prasad RN; Fong YF
Clin Appl Thromb Hemost; 2005 Jul; 11(3):295-301. PubMed ID: 16015415
[TBL] [Abstract][Full Text] [Related]
4. The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis.
Six AJ; Tjon RM; Buys EM; Haas F; Hollander-van Zalk A; Haverkate F
Thromb Haemost; 1990 Aug; 64(1):113-6. PubMed ID: 2148844
[TBL] [Abstract][Full Text] [Related]
5. Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle.
Chaireti R; Gustafsson KM; Byström B; Bremme K; Lindahl TL
Hum Reprod; 2013 Jul; 28(7):1846-52. PubMed ID: 23592222
[TBL] [Abstract][Full Text] [Related]
6. Haemostatic and fibrinolytic properties of peritoneal fluid in the menstrual cycle.
Bouckaert PX; van Wersch JW; Schellekens LA; Evers JL; Rolland R
Br J Obstet Gynaecol; 1984 Mar; 91(3):256-9. PubMed ID: 6422977
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
[TBL] [Abstract][Full Text] [Related]
8. Variations in blood coagulation, fibrinolysis, platelet function and various plasma proteins during the menstrual cycle.
Cederblad G; Hahn L; Korsan-Bengtsen K; Pehrsson NG; Rybo G
Haemostasis; 1977; 6(5):294-302. PubMed ID: 598750
[TBL] [Abstract][Full Text] [Related]
9. Haemostatic variables during normal menstrual cycle. A systematic review.
Knol HM; Kemperman RF; Kluin-Nelemans HC; Mulder AB; Meijer K
Thromb Haemost; 2012 Jan; 107(1):22-9. PubMed ID: 22159564
[TBL] [Abstract][Full Text] [Related]
10. Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial.
Ricci G; Cerneca F; Simeone R; Pozzobon C; Guarnieri S; Sartore A; Pregazzi R; Guaschino S
Hum Reprod; 2004 Apr; 19(4):838-48. PubMed ID: 15016779
[TBL] [Abstract][Full Text] [Related]
11. Variation in risk indicators of cardiovascular disease during the menstrual cycle: an investigation of within-subject variations in glutathione peroxidase, haemostatic variables, lipids and lipoproteins in healthy young women.
Larsen LF; Andersen HR; Hansen AB; Andersen O
Scand J Clin Lab Invest; 1996 May; 56(3):241-9. PubMed ID: 8761528
[TBL] [Abstract][Full Text] [Related]
12. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
[TBL] [Abstract][Full Text] [Related]
13. Lipid metabolism and coagulation during the normal menstrual cycle.
Lebech AM; Kjaer A
Horm Metab Res; 1989 Aug; 21(8):445-8. PubMed ID: 2507434
[TBL] [Abstract][Full Text] [Related]
14. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
15. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
16. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
[TBL] [Abstract][Full Text] [Related]
17. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
[TBL] [Abstract][Full Text] [Related]
19. Parameters of fibrinolysis in peritoneal fluid and plasma in different stages of the menstrual cycle.
Dörr PJ; Brommer EJ; Dooijewaard G; Vemer HM
Thromb Haemost; 1993 Nov; 70(5):873-5. PubMed ID: 8128449
[TBL] [Abstract][Full Text] [Related]
20. Sequential study of plasma euglobulin fibrinolytic activity during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
Jespersen J
Gynecol Obstet Invest; 1983; 15(5):266-74. PubMed ID: 6852646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
